Description
An anticonvulsant; shortens the duration of the tonic extensor aspect of seizures induced by maximal electroshock in rats when administered at doses ranging from 500-1,000 mg/kg; decreases the duration of the tonic phase of seizures at a dose of 1,000 mg/kg but does not affect the duration of the clonic phase at any dose; decreases serum cholesterol and triglyceride concentrations in mice to 67 and 60%, respectively, of control when administered at a dose of 20 mg/kg, i.p., for 16 days
Formal name: 3-ethyl-5-phenyl-2,4-imidazolidinedione
Synonyms: (±)-Ethotoin
Molecular weight: 204.2
CAS: 86-35-1
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals||Research Area|Neuroscience|Seizure Disorders
